$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC.

2023 Q3 Form 10-Q Financial Statement

#000107997323001057 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $2.594M $2.308M
YoY Change 22.54% 12.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.145M $961.5K
YoY Change 12.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.620K $6.260K
YoY Change -58.88%
% of Gross Profit
Operating Expenses $1.413M $1.154M
YoY Change 11.56%
Operating Profit
YoY Change
Interest Expense $1.027M $906.2K
YoY Change 60.03% 86.91%
% of Operating Profit
Other Income/Expense, Net $23.92K $35.58K
YoY Change -28.71% -23.03%
Pretax Income $154.5K $248.7K
YoY Change -26.05% -1.76%
Income Tax $37.56K $72.64K
% Of Pretax Income 24.31% 29.21%
Net Earnings $116.9K $176.0K
YoY Change -24.43% -5.02%
Net Earnings / Revenue 4.51% 7.63%
Basic Earnings Per Share $0.03 $0.05
Diluted Earnings Per Share $0.03 $0.05
COMMON SHARES
Basic Shares Outstanding 2.905M shares 2.905M shares
Diluted Shares Outstanding 3.259M shares 3.246M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $147.8K
YoY Change -100.0%
Cash & Equivalents $0.00 $147.8K
Short-Term Investments
Other Short-Term Assets $261.0K $393.7K
YoY Change 30.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $60.02M $56.32M
YoY Change 13.3% 10.12%
LONG-TERM ASSETS
Property, Plant & Equipment $93.57K $98.42K
YoY Change 9.03% 7.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.005M $935.4K
YoY Change 6.93%
Total Long-Term Assets $1.251M $1.219M
YoY Change -4.15% -2.18%
TOTAL ASSETS
Total Short-Term Assets $60.02M $56.32M
Total Long-Term Assets $1.251M $1.219M
Total Assets $61.27M $57.54M
YoY Change 12.88% 9.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.555M $1.583M
YoY Change 6.55%
Deferred Revenue
YoY Change
Short-Term Debt $44.49M $40.89M
YoY Change 18.63%
Long-Term Debt Due $2.899M $2.279M
YoY Change 179.39%
Total Short-Term Liabilities $48.95M $44.76M
YoY Change 22.36% 15.68%
LONG-TERM LIABILITIES
Long-Term Debt $6.034M $6.581M
YoY Change -28.51%
Other Long-Term Liabilities $39.71K $48.87K
YoY Change -61.64%
Total Long-Term Liabilities $6.074M $6.630M
YoY Change -28.91% -18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.95M $44.76M
Total Long-Term Liabilities $6.074M $6.630M
Total Liabilities $55.02M $51.39M
YoY Change 13.34% 9.82%
SHAREHOLDERS EQUITY
Retained Earnings $2.840M $2.753M
YoY Change 20.67% 23.75%
Common Stock $2.905K $2.905K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.248M $6.153M
YoY Change
Total Liabilities & Shareholders Equity $61.27M $57.54M
YoY Change 12.88% 9.83%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $116.9K $176.0K
YoY Change -24.43% -5.02%
Depreciation, Depletion And Amortization $6.620K $6.260K
YoY Change -58.88%
Cash From Operating Activities $670.2K $881.8K
YoY Change -59.92%
INVESTING ACTIVITIES
Capital Expenditures $1.770K $7.350K
YoY Change -92.86%
Acquisitions
YoY Change
Other Investing Activities -$4.286M -$3.923M
YoY Change -35.76%
Cash From Investing Activities -$4.288M -$3.930M
YoY Change -35.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.470M 2.936M
YoY Change -31.97%
NET CHANGE
Cash From Operating Activities 670.2K 881.8K
Cash From Investing Activities -4.288M -3.930M
Cash From Financing Activities 3.470M 2.936M
Net Change In Cash -147.8K -112.7K
YoY Change -294.85%
FREE CASH FLOW
Cash From Operating Activities $670.2K $881.8K
Capital Expenditures $1.770K $7.350K
Free Cash Flow $668.4K $874.4K
YoY Change -59.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001807893
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56243
dei Entity Registrant Name
EntityRegistrantName
STANDARD PREMIUM FINANCE HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2624094
dei Entity Address Address Line1
EntityAddressAddressLine1
13590 SW 134th Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 214
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33186
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
232-2752
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2905016 shares
CY2023Q2 us-gaap Cash
Cash
147800 usd
CY2022Q4 us-gaap Cash
Cash
421211 usd
CY2023Q2 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
1230263 usd
CY2022Q4 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
1129498 usd
CY2023Q2 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
55778974 usd
CY2022Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
49474903 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
393724 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
348795 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
56320498 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50244909 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98424 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103591 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139465 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196407 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
45292 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
51920 usd
CY2023Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
618362 usd
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
603816 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
317000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
288164 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
935362 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
891980 usd
CY2023Q2 us-gaap Assets
Assets
57539041 usd
CY2022Q4 us-gaap Assets
Assets
51488807 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
38032709 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
32713625 usd
CY2023Q2 srt Drafts Payable
DraftsPayable
2861946 usd
CY2022Q4 srt Drafts Payable
DraftsPayable
1827884 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1579091 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1340597 usd
CY2023Q2 spfx Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
587000 usd
CY2022Q4 spfx Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
109000 usd
CY2023Q2 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
99963 usd
CY2022Q4 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
91852 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90597 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122554 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12826 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12494 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1492045 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1317699 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44756177 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37535705 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
5127922 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
5946324 usd
CY2023Q2 spfx Note Payable Stockholders And Related Parties Net Of Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfCurrentPortion
1341000 usd
CY2022Q4 spfx Note Payable Stockholders And Related Parties Net Of Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfCurrentPortion
1816000 usd
CY2023Q2 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
77649 usd
CY2022Q4 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
123924 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48868 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73853 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
34062 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
40559 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6629501 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8000660 usd
CY2023Q2 us-gaap Liabilities
Liabilities
51385678 usd
CY2022Q4 us-gaap Liabilities
Liabilities
45536365 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3397751 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3383651 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2752541 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2565720 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6153363 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5952442 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57539041 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51488807 usd
CY2023Q2 us-gaap Revenues
Revenues
2308439 usd
CY2022Q2 us-gaap Revenues
Revenues
2042982 usd
us-gaap Revenues
Revenues
4387243 usd
us-gaap Revenues
Revenues
3925578 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
906166 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
484816 usd
us-gaap Interest Expense
InterestExpense
1697813 usd
us-gaap Interest Expense
InterestExpense
911306 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
421825 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
366608 usd
us-gaap Salaries And Wages
SalariesAndWages
851075 usd
us-gaap Salaries And Wages
SalariesAndWages
727307 usd
CY2023Q2 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
271137 usd
CY2022Q2 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
257711 usd
us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
513572 usd
us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
498560 usd
CY2023Q2 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
154928 usd
CY2022Q2 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
271144 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
346781 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
439249 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
78013 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
88331 usd
us-gaap Professional Fees
ProfessionalFees
165833 usd
us-gaap Professional Fees
ProfessionalFees
194133 usd
CY2023Q2 us-gaap Postage Expense
PostageExpense
28811 usd
CY2022Q2 us-gaap Postage Expense
PostageExpense
28686 usd
us-gaap Postage Expense
PostageExpense
56689 usd
us-gaap Postage Expense
PostageExpense
54052 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
35577 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
46223 usd
us-gaap Other Expenses
OtherExpenses
63051 usd
us-gaap Other Expenses
OtherExpenses
90067 usd
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
163303 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
246329 usd
us-gaap Other General Expense
OtherGeneralExpense
364002 usd
us-gaap Other General Expense
OtherGeneralExpense
457082 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2059760 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1789848 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4058816 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3371756 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
248679 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
253134 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
328427 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
553822 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72638 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67781 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83506 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
143404 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176041 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
185353 usd
us-gaap Net Income Loss
NetIncomeLoss
244921 usd
us-gaap Net Income Loss
NetIncomeLoss
410418 usd
CY2023Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
29050 usd
CY2022Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
17558 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
58100 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
34883 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
146991 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
167795 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
186821 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
375535 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3246005 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3129657 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3311067 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3129657 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4534779 usd
CY2022Q1 spfx Series A Convertible Preferred Stock Issued In Exchange For Note Payable
SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable
20000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5778 usd
CY2022Q1 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-17325 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225065 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4768297 usd
CY2022Q2 spfx Series A Convertible Preferred Stock Issued In Exchange For Note Payable
SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable
650000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10800 usd
CY2022Q2 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-17558 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
185353 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
5596892 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5952442 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7050 usd
CY2023Q1 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-29050 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
68880 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5999322 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7050 usd
CY2023Q2 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-29050 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
176041 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6153363 usd
us-gaap Net Income Loss
NetIncomeLoss
244921 usd
us-gaap Net Income Loss
NetIncomeLoss
410418 usd
us-gaap Depreciation
Depreciation
12515 usd
us-gaap Depreciation
Depreciation
10322 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2167 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
56942 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50931 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6628 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6628 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
346781 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
439249 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-57038 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-33508 usd
spfx Options Issued For Services
OptionsIssuedForServices
14100 usd
spfx Options Issued For Services
OptionsIssuedForServices
5778 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
10800 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
44929 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-172209 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
28836 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-3000 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
1034062 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
331762 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
174346 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-294099 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-56942 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-50931 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1816626 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1131742 usd
spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
6650852 usd
spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
4358311 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
14546 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
13653 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4500 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7348 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24800 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6672746 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4392264 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-153264 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
5262046 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3285079 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
91668 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
325000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
671576 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
236000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
27000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
181302 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
6165 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
5851 usd
spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
38164 usd
spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
-0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
400000 usd
spfx Dividend Distributions Paid
DividendDistributionsPaid
58100 usd
spfx Dividend Distributions Paid
DividendDistributionsPaid
34883 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4582709 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3423779 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-273411 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
163257 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
421211 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20987 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147800 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184244 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36041 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
239059 usd
us-gaap Interest Paid Net
InterestPaidNet
1652987 usd
us-gaap Interest Paid Net
InterestPaidNet
879481 usd
spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
0 usd
spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
270000 usd
CY2023Q2 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
58205806 usd
CY2022Q4 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
51525950 usd
CY2023Q2 us-gaap Unearned Premiums
UnearnedPremiums
80521039 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Unearned Premiums
UnearnedPremiums
71315354 usd
us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.167 pure
us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.150 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zolDkjxRxLb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_861_zqVXPW2h8uei">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for doubtful accounts, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zxBiOCfPdMMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86B_zMwqL003tdq7">Concentration of Credit and Financial Instrument Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and loans receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at these financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_c20230630_pp0p0" title="FDIC insured amount">250,000</span>. Uninsured balances are $<span id="xdx_903_eus-gaap--CashUninsuredAmount_c20230630_pp0p0" title="Uninsured balances">63,779</span> and $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20221231_pp0p0" title="Uninsured balances">482,479</span> at June 30, 2023 and December 31, 2022, respectively. The Company mitigates this risk by maintaining its cash balances at high-quality financial institutions. The following table provides a reconciliation between uninsured balances and cash per the balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_zeDELlNTWs4e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B7_zBcXYrq80e6b" style="display: none">Schedule of reconciliation between uninsured balances and cash per the balance sheet</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20230630" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>June 30, 2023 <br/>(unaudited)</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2022</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_402_eus-gaap--CashUninsuredAmount_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">63,779</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">482,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PlusInsuredBalances_iI_pp0p0_zhISePX5LA67" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0_zCiSHtPJHik3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Plus: Balances at institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">145,453</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--OutstandingChecks_iI_pp0p0_zx5BZlk8YIU9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(311,432</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(329,026</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Cash_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cash per Consolidated Balance Sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">147,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">421,211</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--FL_zHee806ZEask" title="Concentration risk percentage">61</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__srt--StatementGeographicalAxis__stpr--FL_zGJ3rmhss4bj" title="Concentration risk percentage">56</span>% of the Company’s business activity is with customers located in Florida for 2023 and 2022, respectively. Approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--GA_ztG9iTHUwIe6" title="Concentration risk percentage">10</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__srt--StatementGeographicalAxis__stpr--GA_zD9BH163Mwfj" title="Concentration risk percentage">14</span>% of the Company’s business activity is with customers located in Georgia for 2023 and 2022, respectively. Approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--NC_zuiVQraYKw3f" title="Concentration risk percentage">12</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__srt--StatementGeographicalAxis__stpr--NC_zh0P5INkP7Eg" title="Concentration risk percentage">14</span>% of the Company's business activity is with customers located in North Carolina for 2023 and 2022, respectively. There were no other significant regional, industrial or group concentrations during the three months ended June 30, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
63779 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
482479 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
63779 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
482479 usd
CY2023Q2 spfx Plus Insured Balances
PlusInsuredBalances
250000 usd
CY2022Q4 spfx Plus Insured Balances
PlusInsuredBalances
250000 usd
CY2023Q2 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
145453 usd
CY2022Q4 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
17758 usd
CY2023Q2 spfx Outstanding Checks
OutstandingChecks
-311432 usd
CY2022Q4 spfx Outstanding Checks
OutstandingChecks
-329026 usd
CY2023Q2 us-gaap Cash
Cash
147800 usd
CY2022Q4 us-gaap Cash
Cash
421211 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
197400 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
197400 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2023Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
618362 usd
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
603816 usd
CY2023Q2 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
52802001 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
45520349 usd
CY2023Q2 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
5403805 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
6005601 usd
CY2023Q2 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
58205806 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
51525950 usd
CY2023Q2 spfx Amounts Due From Agents
AmountsDueFromAgents
830815 usd
CY2022Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
645648 usd
CY2023Q2 spfx Unearned Interest
UnearnedInterest
2027384 usd
CY2022Q4 spfx Unearned Interest
UnearnedInterest
1567197 usd
CY2023Q2 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
57009237 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
50604401 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1230263 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1129498 usd
CY2023Q2 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
55778974 usd
CY2022Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
49474903 usd
CY2023Q2 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1064827 usd
CY2022Q4 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1000000 usd
CY2023Q2 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
165436 usd
CY2022Q4 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
129498 usd
CY2023Q2 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
58205806 usd
CY2022Q4 spfx Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
45520349 usd
CY2022Q4 spfx Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
6005601 usd
CY2022Q4 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
51525950 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129498 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
spfx Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
719000 usd
CY2022 spfx Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
1347475 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
775478 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1513814 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
157243 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
102080 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1230263 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129498 usd
CY2023Q2 spfx Current Additions To Allowance
CurrentAdditionsToAllowance
320000 usd
CY2022Q2 spfx Current Additions To Allowance
CurrentAdditionsToAllowance
380000 usd
CY2023Q2 spfx Contra Rrevenues
ContraRrevenues
165072 usd
CY2022Q2 spfx Contra Rrevenues
ContraRrevenues
108856 usd
CY2023Q2 spfx Provision For Credit Losses
ProvisionForCreditLosses
154928 usd
CY2022Q2 spfx Provision For Credit Losses
ProvisionForCreditLosses
271144 usd
spfx Total Provision
TotalProvision
719000 usd
spfx Total Provision
TotalProvision
715000 usd
spfx Less Contrarevenues
LessContrarevenues
-372219 usd
spfx Less Contrarevenues
LessContrarevenues
-275751 usd
spfx Bad Debt Expense
BadDebtExpense
346781 usd
spfx Bad Debt Expense
BadDebtExpense
439249 usd
CY2023Q2 spfx Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
52802001 usd
CY2023Q2 spfx Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
5403805 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355746 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
348399 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
257322 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244808 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98424 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103591 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6258 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5781 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12515 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10322 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M2D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
31382 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
28194 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
61438 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
56387 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139465 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196407 usd
CY2023Q2 spfx Server Lease
ServerLease
45292 usd
CY2022Q4 spfx Server Lease
ServerLease
51920 usd
CY2023Q2 spfx Total Lease Assets
TotalLeaseAssets
184757 usd
CY2022Q4 spfx Total Lease Assets
TotalLeaseAssets
248327 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90597 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122554 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48868 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73853 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
139465 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
196407 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12826 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12494 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
34062 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
40559 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
46888 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
53053 usd
CY2023Q2 srt Drafts Payable
DraftsPayable
2861946 usd
CY2022Q4 srt Drafts Payable
DraftsPayable
1827884 usd
CY2022Q4 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
25771 usd
CY2022Q4 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
117228 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
7801 usd
CY2023Q2 us-gaap Other Notes Payable
OtherNotesPayable
177612 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
215776 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
99963 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
91852 usd
CY2023Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
77649 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
123924 usd
CY2023Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
120000 usd
CY2022Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
123000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
248000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
251000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
91668 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
325000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
671576 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
236000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
250000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
25000 shares
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
40000 usd
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
41000 usd
us-gaap Interest Expense Other
InterestExpenseOther
79000 usd
us-gaap Interest Expense Other
InterestExpenseOther
80000 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
30000 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
25000 usd
spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
27000 usd
spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
181032 usd
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 spfx Designated Shares
DesignatedShares
600000 shares
CY2023Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2023Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
1689050 usd
CY2023Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2023Q2 us-gaap Dividends
Dividends
29050 usd
CY2022Q2 us-gaap Dividends
Dividends
17558 usd
us-gaap Dividends
Dividends
58100 usd
us-gaap Dividends
Dividends
34883 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
197400 shares
spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y1M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1091236 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
spfx Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y7M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
780236 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
197400 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.00
spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y7M28D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
778036 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7050 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14100 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5778 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1549400 usd
spfx Warrants Issued
WarrantsIssued
0 shares
spfx Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
spfx Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y29D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
596900 usd
CY2023Q2 spfx Warrants Exercisable
WarrantsExercisable
1035000 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y29D
CY2023Q2 spfx Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1
596900 usd
CY2022Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
10800 usd
CY2021Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
9275 usd
CY2020Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
27200 usd
CY2023Q2 spfx Stock Warrant Expense
StockWarrantExpense
0 usd
CY2022Q2 spfx Stock Warrant Expense
StockWarrantExpense
10800 usd
spfx Stock Warrant Expense
StockWarrantExpense
0 usd
spfx Stock Warrant Expense
StockWarrantExpense
10800 usd
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2025-11-30
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1928000 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1925000 usd

Files In Submission

Name View Source Status
0001079973-23-001057-index-headers.html Edgar Link pending
0001079973-23-001057-index.html Edgar Link pending
0001079973-23-001057.txt Edgar Link pending
0001079973-23-001057-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spfx-20230630.xsd Edgar Link pending
spfx_10q.htm Edgar Link pending
spfx-20230630_def.xml Edgar Link unprocessable
spfx-20230630_pre.xml Edgar Link unprocessable
spfx-20230630_lab.xml Edgar Link unprocessable
spfx_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
spfx-20230630_cal.xml Edgar Link unprocessable